TTM
$589.26M
YoY change
-291.9%
5Y CAGR
-5.9%
Peak year (2022)
$3.63B
Cumulative EBITDA
$19.27B
EBITDA history chart for Albemarle (ALB) from 1993 to 2025
Latest: $559.90M
EBITDA growth chart for Albemarle (ALB) from 1993 to 2025
Latest: -291.9%
EBITDA history table for Albemarle (ALB) from 1993 to 2025
| 2025 | $559.90M | -291.9% | +$851.74M | ||
| 2024 | −$291.83M | -111.0% | −$2.94B | ||
| 2023 | $2.65B | -27.1% | −$982.70M | ||
| 2022 | $3.63B | +566.1% | +$3.08B | ||
| 2021 | $544.86M | -28.1% | −$212.83M | ||
| 2020 | $757.70M | -15.7% | −$141.11M | ||
| 2019 | $898.81M | -2.8% | −$26.20M | ||
| 2018 | $925.01M | +12.9% | +$105.52M | ||
| 2017 | $819.49M | +11.4% | +$83.68M | ||
| 2016 | $735.81M | +0.7% | +$5.12M | ||
| 2015 | $730.68M | +69.5% | +$299.71M | ||
| 2014 | $430.98M | -40.4% | −$292.67M | ||
| 2013 | $723.64M | +18.9% | +$114.87M | ||
| 2012 | $608.77M | -11.1% | −$75.82M | ||
| 2011 | $684.59M | +32.3% | +$167.21M | ||
| 2010 | $517.38M | +66.5% | +$206.56M | ||
| 2009 | $310.83M | -21.7% | −$86.11M | ||
| 2008 | $396.94M | -5.9% | −$24.75M | ||
| 2007 | $421.69M | +11.1% | +$42.08M | ||
| 2006 | $379.61M | +21.6% | +$67.52M | ||
| 2005 | $312.08M | +67.8% | +$126.15M | ||
| 2004 | $185.93M | +5.1% | +$9.10M | ||
| 2003 | $176.84M | -3.6% | −$6.58M | ||
| 2002 | $183.42M | +4.2% | +$7.36M | ||
| 2001 | $176.06M | -21.4% | −$47.85M | ||
| 2000 | $223.91M | +11.6% | +$23.31M | ||
| 1999 | $200.60M | -0.1% | −$200.00K | ||
| 1998 | $200.80M | +5.8% | +$11.00M | ||
| 1997 | $189.80M | +15.5% | +$25.40M | ||
| 1996 | $164.40M | -22.1% | −$46.70M | ||
| 1995 | $211.10M | +12.8% | +$23.90M | ||
| 1994 | $187.20M | +36.5% | +$50.10M | ||
| 1993 | $137.10M | — | — |
- 2025$559.90M-291.9%
- 2024−$291.83M-111.0%
- 2023$2.65B-27.1%
- 2022$3.63B+566.1%
- 2021$544.86M-28.1%
- 2020$757.70M-15.7%
- 2019$898.81M-2.8%
- 2018$925.01M+12.9%
- 2017$819.49M+11.4%
- 2016$735.81M+0.7%
- 2015$730.68M+69.5%
- 2014$430.98M-40.4%
- 2013$723.64M+18.9%
- 2012$608.77M-11.1%
- 2011$684.59M+32.3%
- 2010$517.38M+66.5%
- 2009$310.83M-21.7%
- 2008$396.94M-5.9%
- 2007$421.69M+11.1%
- 2006$379.61M+21.6%
- 2005$312.08M+67.8%
- 2004$185.93M+5.1%
- 2003$176.84M-3.6%
- 2002$183.42M+4.2%
- 2001$176.06M-21.4%
- 2000$223.91M+11.6%
- 1999$200.60M-0.1%
- 1998$200.80M+5.8%
- 1997$189.80M+15.5%
- 1996$164.40M-22.1%
- 1995$211.10M+12.8%
- 1994$187.20M+36.5%
- 1993$137.10M—
EBITDA values are taken from Albemarle's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Albemarle (ALB)
According to Albemarle's latest reported financial statements, the company's current EBITDA (TTM) is $589.26M. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Albemarle (ALB) EBITDA totalled $559.90M – plunged 291.9% year-over-year.
Over 2020–2025 (5 years), Albemarle EBITDA expanded at a -5.9% compound annual rate, with a net decline across the window.
Between 2022 and 2025, Albemarle EBITDA plunged 84.6%, falling from $3.63B to $559.90M.
The highest annual EBITDA of $3.63B was reported in 2022. The lowest in the available history was −$291.83M in 2024.
Albemarle EBITDA by Year
Albemarle EBITDA 2025: $559.90M
2025's EBITDA for Albemarle came in at $559.90M, plunged 291.9% below 2024.
Albemarle EBITDA 2024: −$291.83M
Albemarle posted EBITDA of −$291.83M in 2024, plunged 111.0% below 2023. This figure represents the lowest annual value in the available history.
Albemarle EBITDA 2023: $2.65B
In 2023, Albemarle reported EBITDA of $2.65B, declined 27.1% below 2022.
Albemarle EBITDA 2022: $3.63B
Albemarle EBITDA in 2022 was $3.63B, surged 566.1% from 2021. This figure represents the highest annual value in the available history.
Albemarle EBITDA 2021: $544.86M
Albemarle EBITDA in 2021 was $544.86M.
See more financial history for Albemarle (ALB).
Sector peers by EBITDA
Basic Materials peers of Albemarle (ALB), ranked by their latest EBITDA
| $14.83B | |
| $12.95B | |
| $8.76B | |
| $8.38B | |
| $8.02B | |
| $7.48B | |
| $4.40B | |
| $3.46B |
- $14.83B
- $12.95B
- $8.76B
- $8.38B
- $8.02B
- $7.48B
- $4.40B
- $3.46B
Frequently asked questions
Albemarle (ALB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation